Moreover, a retrospective study in China of 39 patients with COVID-19 and 32 controls showed that the former had significantly increased levels of ICAM-1 and other endothelial adhesion molecules, which may contribute to coagulopathy [22]. The gene discussed is ICAM1; the disease is COVID-19.